Antiviral Drugs for the Treatment of Suspected or Confirmed Influenza A or Influenza B

Details

Project Status:
In Progress
Project Line:
Health Technology Review
Project Sub Line:
Systematic Review
Project Number:
RE0052-000

Influenza is an acute viral respiratory infection that can cause significant morbidity and mortality. In Canada, 4 antiviral drugs are available to treat influenza. Early treatment has been shown to lead to a shorter duration of symptoms and fewer complications.

The findings of the query will be used to support multijurisdictional decision-making related to the safe and appropriate use of antiviral drugs for influenza A or B for pandemic preparedness.


Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.

The “Projects in Progress” page on the Canada's Drug Agency website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.